Posted in Business BTIG Reiterates a Buy Rating on Denali Therapeutics (DNLI) With a $32 Price Target Estimated read time 2 min read Posted on July 18, 2025 by Joelgalvan Denali Therapeutics, Inc. (NASDAQ:DNLI) is one of the best oversold NASDAQ stocks to buy now. In a report released on…
